The immune system can be broken down into two general components: the innate immune system and the adaptive immune system.

The innate immune system is the first line of defense for the body. It responds within minutes against a wide variety of infections and not only helps to protect the body from invading pathogens, but also triggers the slower, more specific adaptive immune response.

In contrast, the adaptive immune system provides an antigen-specific response that develops over weeks, but can provide long term resistance.

An ideal response to a pathogen is when these two systems work together. As illustrated, the innate response responds first, providing the body immediate protection while the adaptive immune system responds accordingly. With technology that can boost the immediate, innate response, our body is better positioned to fight against inhaled pathogens.


  • Completed two Phase I clinical trials
  • Technology developed to a lead compound of synthetic molecules that can be mass produced
  • Technology published in multiple leading peer-reviewed journals
  • Strong and expanding patent portfolio—composition and use patent claims issued in eight countries to date, including the US
  • >$25 million received to date in grant and equity funding